These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10502619)

  • 1. Reduction of tablet coloration at tableting for oily medicine (tocopheryl nicotinate).
    Takashima Y; Yuasa H; Kanaya Y; Nomura I; Shinozawa K
    Int J Pharm; 1999 Sep; 187(1):125-35. PubMed ID: 10502619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of calcium silicate for medicinal preparation. I. Solid preparation adsorbing an oily medicine to calcium silicate.
    Yuasa H; Asahi D; Takashima Y; Kanaya Y; Shinozawa K
    Chem Pharm Bull (Tokyo); 1994 Nov; 42(11):2327-31. PubMed ID: 7859331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adsorption of meloxicam on porous calcium silicate: characterization and tablet formulation.
    Sharma S; Sher P; Badve S; Pawar AP
    AAPS PharmSciTech; 2005 Dec; 6(4):E618-25. PubMed ID: 16408863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tableting properties of silica aerogel and other silicates.
    Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS
    Drug Dev Ind Pharm; 2012 Apr; 38(4):462-7. PubMed ID: 21961994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of orally disintegrating tablets containing vitamin E as a model fat-soluble drug.
    Ikematsu Y; Uchida S; Namiki N
    Chem Pharm Bull (Tokyo); 2015; 63(3):156-63. PubMed ID: 25757486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
    Jung HA; Augsburger LL
    Drug Dev Ind Pharm; 2012 Jul; 38(7):825-36. PubMed ID: 22091970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on internal structure of tablets. VI. stress dispersion in tablets by excipients.
    Yuasa H; Akutagawa M; Hashizume T; Kanaya Y
    Chem Pharm Bull (Tokyo); 1996 Feb; 44(2):378-82. PubMed ID: 8998842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced dissolution and oral bioavailability of nifedipine by spontaneous emulsifying powders: effect of solid carriers and dietary state.
    Weerapol Y; Limmatvapirat S; Jansakul C; Takeuchi H; Sriamornsak P
    Eur J Pharm Biopharm; 2015 Apr; 91():25-34. PubMed ID: 25615879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low density multiparticulate system for pulsatile release of meloxicam.
    Sharma S; Pawar A
    Int J Pharm; 2006 Apr; 313(1-2):150-8. PubMed ID: 16540268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A methodological evaluation and predictive in silico investigation into the multi-functionality of arginine in directly compressed tablets.
    ElShaer A; Kaialy W; Akhtar N; Iyire A; Hussain T; Alany R; Mohammed AR
    Eur J Pharm Biopharm; 2015 Oct; 96():272-81. PubMed ID: 26255158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tabletting of solid dispersion particles consisting of indomethacin and porous silica particles.
    Takeuchi H; Nagira S; Tanimura S; Yamamoto H; Kawashima Y
    Chem Pharm Bull (Tokyo); 2005 May; 53(5):487-91. PubMed ID: 15863917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets.
    Pabari RM; Ramtoola Z
    Int J Pharm; 2012 Jul; 430(1-2):18-25. PubMed ID: 22465631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of
    Abbas S; Sherazi M; Khan A; Alyami HS; Latif M; Qureshi ZU; Majeedullah ; Asad MHHB
    Biomed Res Int; 2021; 2021():5538075. PubMed ID: 34235217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of three chitin metal silicate co-precipitates as a potential multifunctional single excipient in tablet formulations.
    Hamid RA; Al-Akayleh F; Shubair M; Rashid I; Remawi MA; Badwan A
    Mar Drugs; 2010 May; 8(5):1699-715. PubMed ID: 20559493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly stabilized amorphous 3-bis(4-methoxyphenyl)methylene-2-indolinone (TAS-301) in melt-adsorbed products with silicate compounds.
    Kinoshita M; Baba K; Nagayasu A; Yamabe K; Azuma M; Houchi H; Minakuchi K
    Drug Dev Ind Pharm; 2003 May; 29(5):523-9. PubMed ID: 12779282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
    Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
    Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A material-sparing method for simultaneous determination of true density and powder compaction properties--aspartame as an example.
    Sun CC
    Int J Pharm; 2006 Dec; 326(1-2):94-9. PubMed ID: 16926076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compaction mechanism and tablet strength of unlubricated and lubricated (silicified) microcrystalline cellulose.
    van Veen B; Bolhuis GK; Wu YS; Zuurman K; Frijlink HW
    Eur J Pharm Biopharm; 2005 Jan; 59(1):133-8. PubMed ID: 15567310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of sticking in tablet compaction for tocopherol acetate.
    Sakata Y; Yamaguchi H
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1049-59. PubMed ID: 21417611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Punch geometry and formulation considerations in reducing tablet friability and their effect on in vitro dissolution.
    Chowhan ZT; Amaro AA; Ong JT
    J Pharm Sci; 1992 Mar; 81(3):290-4. PubMed ID: 1640370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.